Speaker profile
Back to full speaker list

Abhishek Pratap

Executive Director - Global Evidence Lead
Boehringer Ingelheim

Dr. Abhishek (Abhi) Pratap is the Executive Director and Global Clinical Development Lead at
Boehringer Ingelheim, leading late-stage development and real-world evidence generation for
digital therapeutics in serious mental illnesses. He recently led a pivotal Phase III trial in
schizophrenia (NCT05838625), the first confirmatory study to demonstrate
improvement in negative symptoms. He has over 15 years of experience translating digital
health, real-world data, and neuroscience into patient-centered, regulatory-aligned evidence. His
work spans pivotal trials, value-based evidence strategies, and large-scale decentralized studies.

Agenda sessions

Day 1 | May 19, 2026
14:35 (CEST)
The Utilisation of Digital to Accelerate the Clinical Development of CNS Therapeutics
Go to session
15:20 (CEST)
Panel Discussion and Q&A
Go to session
_linkedin_partner_id = "8285402"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); (function(l) { if (!l){window.lintrk = function(a,b){window.lintrk.q.push([a,b])}; window.lintrk.q=[]} var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(window.lintrk);